Gainers

• Exascale Labs Holdings (NASDAQ:XLAB) stock increased by 31.6% to $3.58 during Thursday's regular session. The market value of their outstanding shares is at $192.3 million.
• BIO-key International (NASDAQ:BKYI) stock increased by 29.04% to $2.71. The market value of their outstanding shares is at $4.6 million.
• TROOPS (NASDAQ:TROO) stock moved upwards by 27.54% to $2.13. The market value of their outstanding shares is at $199.1 million.
• Tucows (NASDAQ:TCX) stock rose 19.59% to $11.35. The company's market cap stands at $102.1 million.
• The Growhub (NASDAQ:TGHL) stock increased by 16.6% to $0.6. The market value of their outstanding shares is at $12.6 million.
• Sagtec Global (NASDAQ:SAGT) stock moved upwards by 15.1% to $0.65. The market value of their outstanding shares is at $8.8 million.

Losers

• NVE (NASDAQ:NVEC) stock decreased by 32.7% to $69.36 during Thursday's regular session. The market value of their outstanding shares is at $493.6 million. The company's, Q2 earnings came out yesterday.
• TTM Technologies (NASDAQ:TTMI) shares fell 28.78% to $72.76. The market value of their outstanding shares is at $10.0 billion. As per the news, the Q3 earnings report came out today.
• Hub Cyber Security (NASDAQ:HUBC) stock decreased by 26.09% to $0.22.
• ReAlpha Tech (NASDAQ:AIRE) stock declined by 21.56% to $0.8. The company's market cap stands at $5.4 million.
• Cohu (NASDAQ:COHU) shares decreased by 16.52% to $46.16. The company's market cap stands at $2.4 billion.
• Amplitech Group, Inc. - Series B Right (NASDAQ:AMPGZ) stock declined by 15.74% to $0.06. See Also: www.benzinga.com/money/tech-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.